Triangle Pharmaceuticals was acquired in 2003 by Gilead Sciences, who completed development and now market the product with the brand name Emtriva.

Ledipasvir (formerly GS-5885) is an experimental drug for the treatment of hepatitis C being developed by Gilead Sciences.

Shares in Gilead Sciences, another leading anti-sense company, closed at $17.50, up 25 cents.

He is a founding member of the Scientific Advisory Board for Gilead Sciences.

He joined Gilead Sciences in 1990 as Vice President for Research and Development.

Executive vice president, Gilead Sciences.

The patent for oseltamivir is held by Gilead Sciences and is valid at least until 2016.

Study medication was donated by Gilead Sciences.

So far this year one Rockefeller-backed company, Gilead Sciences of Foster City, Calif., has gone public.

Other integrase inhibitors, like one from Gilead Sciences, are also under development.